223 related articles for article (PubMed ID: 23268930)
1. Unconventional secretion is a major contributor of cancer cell line secretomes.
Villarreal L; Méndez O; Salvans C; Gregori J; Baselga J; Villanueva J
Mol Cell Proteomics; 2013 May; 12(5):1046-60. PubMed ID: 23268930
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic reanalysis of public proteomics data reveals that nuclear proteins are recurrent in cancer secretomes.
De Morais JA; Zelanis A
Traffic; 2022 Feb; 23(2):98-108. PubMed ID: 34806804
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
4. Secretome analysis using a hollow fiber culture system for cancer biomarker discovery.
Chiu KH; Chang YH; Liao PC
Biochim Biophys Acta; 2013 Nov; 1834(11):2285-92. PubMed ID: 23376430
[TBL] [Abstract][Full Text] [Related]
5. Pitfalls and opportunities in the characterization of unconventionally secreted proteins by secretome analysis.
Schira-Heinen J; Grube L; Waldera-Lupa DM; Baberg F; Langini M; Etemad-Parishanzadeh O; Poschmann G; Stühler K
Biochim Biophys Acta Proteins Proteom; 2019 Dec; 1867(12):140237. PubMed ID: 31202002
[TBL] [Abstract][Full Text] [Related]
6. Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
Shin J; Kim G; Lee JW; Lee JE; Kim YS; Yu JH; Lee ST; Ahn SH; Kim H; Lee C
Cancer Sci; 2016 Jun; 107(6):828-35. PubMed ID: 27002480
[TBL] [Abstract][Full Text] [Related]
7. Secreted proteins as a fundamental source for biomarker discovery.
Stastna M; Van Eyk JE
Proteomics; 2012 Feb; 12(4-5):722-35. PubMed ID: 22247067
[TBL] [Abstract][Full Text] [Related]
8. Secretome protein signature of human pancreatic cancer stem-like cells.
Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
[TBL] [Abstract][Full Text] [Related]
9. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
[TBL] [Abstract][Full Text] [Related]
10. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
11. In silico approach to predict pancreatic β-cells classically secreted proteins.
Pinheiro-Machado E; Milkewitz Sandberg TO; Pihl C; Hägglund PM; Marzec MT
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32003782
[TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities for cell line secretomes in cancer proteomics.
Méndez O; Villanueva J
Proteomics Clin Appl; 2015 Apr; 9(3-4):348-57. PubMed ID: 25418557
[TBL] [Abstract][Full Text] [Related]
13. Stable Isotope Dynamic Labeling of Secretomes (SIDLS) Identifies Authentic Secretory Proteins Released by Cancer and Stromal Cells.
Hammond DE; Kumar JD; Raymond L; Simpson DM; Beynon RJ; Dockray GJ; Varro A
Mol Cell Proteomics; 2018 Sep; 17(9):1837-1849. PubMed ID: 29915148
[TBL] [Abstract][Full Text] [Related]
14. Proteomic approaches to decipher cancer cell secretome.
Brandi J; Manfredi M; Speziali G; Gosetti F; Marengo E; Cecconi D
Semin Cell Dev Biol; 2018 Jun; 78():93-101. PubMed ID: 28684183
[TBL] [Abstract][Full Text] [Related]
15. A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.
Creaney J; Dick IM; Leon JS; Robinson BW
Cancer Genomics Proteomics; 2017; 14(2):103-117. PubMed ID: 28387650
[TBL] [Abstract][Full Text] [Related]
16. Nanonets Collect Cancer Secretome from Pericellular Space.
Zhou R; Kuang Y; Zhou J; Du X; Li J; Shi J; Haburcak R; Xu B
PLoS One; 2016; 11(4):e0154126. PubMed ID: 27100780
[TBL] [Abstract][Full Text] [Related]
17. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.
Luo X; Liu Y; Wang R; Hu H; Zeng R; Chen H
J Proteomics; 2011 Apr; 74(4):528-38. PubMed ID: 21262398
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Cancer Cell Line Secretomes: A Complementary Source of Disease-Specific Protein Biomarkers.
Dunphy K; Bazou D; Dowling P
Methods Mol Biol; 2023; 2645():277-287. PubMed ID: 37202627
[TBL] [Abstract][Full Text] [Related]
19. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.
Wu CC; Hsu CW; Chen CD; Yu CJ; Chang KP; Tai DI; Liu HP; Su WH; Chang YS; Yu JS
Mol Cell Proteomics; 2010 Jun; 9(6):1100-17. PubMed ID: 20124221
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Profiling of Secreted Proteins, Exosomes, and Microvesicles in Cell Culture Conditioned Media.
Sinha A; Principe S; Alfaro J; Ignatchenko A; Ignatchenko V; Kislinger T
Methods Mol Biol; 2018; 1722():91-102. PubMed ID: 29264800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
